Kusajili – Clinical trials directory

Result of your search per sponsor: Pierre Fabre Dermatologie represented by IRPF

Woman and Man Max 99 years
Pierre Fabre Dermatologie represented by IRPF Update Il y a 4 ans

Efficacy and safety of Hemangiol solution in the treatment of high risk infantile hemangioma. A Multinational Single Arm Study Eficacia y seguridad de la solución Hemangiol en el tratamiento del hemangioma infantil de alto riesgo. Estudio multinacional con un solo grupo de tratamiento To document the efficacy of Hemangiol administered during at least 6 months and up to a maximum of 12 months of age in infants with high risk IH. Documentar la eficacia de Hemangiol administrado...

Country None
organs None
Specialty None

Closed trial

More information